You just read:

Rebiotix Receives Breakthrough Therapy Designation for RBX2660 -- A Microbiota Restoration Therapy (MRT) for the Treatment of Recurrent Clostridium difficile Infection

News provided by

Rebiotix Inc.

Oct 12, 2015, 12:28 ET